Biology Lecture Series – Key Vocabulary
Cellular Communication
- Fundamental components
- Ligand = signaling molecule; specificity determines which cells respond.
- Receptor = protein that binds ligand and initiates signal transduction.
- Cellular response = physiological/biochemical change after signaling.
- Second messenger = small intracellular molecule (e.g., cAMP, Ca²⁺) created by some membrane receptors; amplifies signal.
- Receptor categories
- Intracellular receptors
- Bind hydrophobic ligands able to cross membrane (e.g., steroid hormones).
- Often function as transcription factors → gene expression changes.
- Cell-surface (membrane) receptors
- Transmembrane proteins; bind hydrophilic ligands that do NOT enter cell.
- Receptor conveys information across membrane; may generate second messengers.
- Sub-types include kinase-linked receptors (e.g., insulin receptor), G-protein coupled receptors, ion-channel receptors.
- Distance-based signaling types
- Direct contact: surface molecules interact (e.g., immune synapse); gap junctions allow ion/metabolite movement.
- Paracrine: local mediator acts on neighboring cells; short-lived growth factors.
- Autocrine: cell targets itself.
- Endocrine: hormones travel via bloodstream; long-lived, distant effects.
- Synaptic: neurons release neurotransmitter across synapse; rapid, localized.
- Signal transduction themes
- Modular cascades; each step offers branching, amplification, and regulation.
- Reversible phosphorylation central: Protein kinases add P_i from ATP; phosphatases remove it.
- Phosphorylation alters protein conformation, localization, stability, or enzymatic activity.
- Analogy: ligand-receptor binding parallels enzyme-substrate interaction—high specificity, saturable, reversible.
- Energy definitions
- Energy = capacity to do work; measured as heat (calories/kilocalories).
- Kinetic: energy of motion; Potential: stored energy (chemical, electrical, positional).
- Forms: mechanical, heat, light, sound, electrical, radioactive.
- Bioenergetics governed by thermodynamics
- 1st Law: Energy is neither created nor destroyed; only converted; total universal energy constant.
- 2nd Law: Every energy conversion increases entropy S; systems proceed toward disorder; conversions never 100 % efficient (heat loss).
- Free energy (Gibbs)
- G = H - TS where H = enthalpy, T = absolute temperature, S increasing favors spontaneity.
- Change in reaction: \Delta G = \Delta H - T\Delta S.
- \Delta G < 0 → exergonic, spontaneous.
- \Delta G > 0 → endergonic, non-spontaneous (requires energy input).
- Activation Energy E_a
- Extra energy required to destabilize bonds and initiate reaction; lowered by catalysts (enzymes).
ATP – Cellular Energy Currency
- ATP structure: ribose + adenine + three phosphates; terminal phosphoanhydride bonds unstable.
- Hydrolysis: \text{ATP} + H2O \rightarrow \text{ADP} + Pi\;\; (\Delta G \approx -7.3\, \text{kcal·mol}^{-1}) releases energy to drive endergonic processes.
- ATP regenerated continuously via exergonic pathways (substrate-level & oxidative phosphorylation).
Enzymes
- Biological catalysts (mostly proteins); lower E_a, accelerate reactions; not consumed.
- Substrate binds active site—induced-fit model.
- Environmental factors: temperature, pH, ionic strength.
- Regulation
- Competitive inhibitors: bind active site.
- Noncompetitive/allosteric inhibitors: bind other site, alter shape.
- Allosteric activators enhance affinity.
- Feedback inhibition: end product inhibits earlier enzyme (metabolic control).
- Cofactors
- Metal ions or organic coenzymes (e.g., B-vitamins, NAD⁺/FAD).
- Catalytic cycle example: sucrase cleaving sucrose → glucose + fructose.
- Metabolism = sum of all cellular reactions.
- Catabolic: break down molecules; release energy (exergonic).
- Anabolic: synthesize molecules; consume energy (endergonic).
- Biochemical pathways: sequential enzyme steps; product of one reaction becomes substrate for next.
Cellular Respiration (Aerobic)
- Overall equation: C6H{12}O6 + 6O2 \rightarrow 6CO2 + 6H2O + \text{energy} \; (\Delta G \approx -686\, \text{kcal·mol}^{-1}).
- Electron carriers: NAD⁺ ⇌ NADH + H⁺ (accepts 2 e⁻ + H⁺); FAD ⇌ FADH₂ (accepts 2 e⁻ + 2 H⁺).
- ATP formation mechanisms
- Substrate-level phosphorylation (SLP): direct P_i transfer to ADP.
- Oxidative phosphorylation (OP): ATP synthase driven by proton gradient (chemiosmosis).
Stage 1 – Glycolysis (cytoplasm)
- 10-step pathway; glucose (6 C) → 2 × pyruvate (3 C).
- Investment: 2 ATP; Payoff: 4 ATP (net 2), 2 NADH, 2 H₂O.
- Splits into energy investment (G3P formation) and energy payoff (pyruvate, ATP generation).
- Fate of NADH/pyruvate depends on O₂ availability.
- Aerobic: NADH oxidized in ETC; pyruvate → acetyl-CoA.
- Anaerobic: fermentation regenerates NAD⁺ (lactate or ethanol pathways).
Stage 2 – Pyruvate Oxidation (mitochondrial matrix or prokaryotic membrane)
- Pyruvate + CoA + NAD⁺ → acetyl-CoA (2 C) + NADH + CO₂ + H⁺.
- Catalyzed by pyruvate dehydrogenase complex; links glycolysis to Krebs.
Stage 3 – Krebs (Citric Acid) Cycle (matrix)
- Acetyl-CoA (2 C) + oxaloacetate (4 C) → citrate (6 C); cycle regenerates oxaloacetate.
- Per acetyl-CoA: 3 NADH, 1 FADH₂, 1 ATP (via SLP), 2 CO₂.
Stage 4 – Electron Transport Chain & Chemiosmosis (inner mitochondrial membrane)
- Complexes I–IV pass electrons from NADH/FADH₂ to O₂ → H₂O.
- Energy released pumps H⁺ from matrix to intermembrane space (≈53 kcal·mol⁻¹ total).
- Proton-motive force drives ATP synthase; ≈28 ATP produced via OP per glucose.
Yield Summary (eukaryotes)
- Glycolysis: 2 ATP (SLP) + 2 NADH.
- Pyruvate oxidation: 2 NADH.
- Krebs: 2 ATP (SLP) + 6 NADH + 2 FADH₂.
- OP: ~26–28 ATP (using NADH/FADH₂; P/O ratios ≈ 2.5 & 1.5).
- Total ≈ 30–32 ATP per glucose (lower in eukaryotes due to NADH shuttle costs).
Regulation
- Feedback inhibition checkpoints
- Phosphofructokinase (PFK) inhibited by ATP & citrate; activated by ADP.
- Pyruvate dehydrogenase inhibited by NADH.
- Citrate synthase inhibited by ATP.
Alternative Fuels
- Proteins → amino acids → deamination → intermediates (e.g., α-ketoglutarate).
- Fats → glycerol + fatty acids; β-oxidation produces acetyl-CoA + NADH + FADH₂ (6-C fatty acid yields ~20 % more ATP than glucose).
- Fat oxidation requires O₂; anaerobic fat catabolism not possible.
Photosynthesis (Brief Contrast)
- Light reactions: capture solar energy → ATP + NADPH; split H₂O → O₂.
- Calvin cycle (light-independent): uses ATP/NADPH to fix CO₂ → glucose.
- Respiration is essentially the reverse redox flow (glucose oxidation, O₂ reduction).
Cell Cycle & Mitosis
- Phases: G₁ → S → G₂ → Mitosis (M) → Cytokinesis (C).
- Interphase = G₁ + S + G₂.
- Chromosome organization
- Chromatin → nucleosomes (DNA wrapped around histone octamer: H2A, H2B, H3, H4).
- During S: replication → sister chromatids joined at centromere via cohesins.
- Kinetochore forms for spindle attachment.
- Mitosis stages
- Prophase: chromosomes condense; spindle forms; nuclear envelope breaks.
- Prometaphase: microtubules attach to kinetochores.
- Metaphase: chromosomes align on metaphase plate.
- Anaphase: cohesins degraded; sister chromatids pulled to poles.
- Telophase: nuclear envelopes re-form; chromosomes decondense.
- Cytokinesis
- Animal cells: actin-myosin ring → cleavage furrow.
- Plant cells: vesicles form cell plate.
- Cell-cycle control
- Cyclins synthesized cyclically; activate cyclin-dependent kinases (Cdks).
- Checkpoints:
- G₁/S (“restriction point”): assesses size, nutrients, DNA integrity.
- G₂/M: verifies DNA replication & integrity.
- Spindle checkpoint (metaphase): ensures all kinetochores attached.
- Growth factors (e.g., PDGF) activate signaling pathways (Ras/Raf/MEK/ERK) → cyclin gene expression.
Cancer Genetics
- Tumor-suppressor genes (loss-of-function → cancer)
- p53: halts cycle, induces repair or apoptosis; mutated in ~50 % cancers.
- Rb: regulates G₁/S transition; mutated in ~40 % cancers.
- Proto-oncogenes (gain-of-function when mutated → oncogenes)
- Growth-factor receptors (e.g., HER2).
- Ras GTPase (mutated in 20–30 % cancers).
- Src kinase.
Meiosis & Sexual Reproduction
- Purpose: produce haploid gametes from diploid germ-line cells; enables genetic diversity and chromosome number constancy across generations.
- Two successive divisions (Meiosis I & II) with one DNA replication.
- Key events
- Prophase I: homologous chromosomes undergo synapsis forming tetrads; crossing over at chiasmata (genetic recombination).
- Metaphase I: tetrads align randomly (independent assortment).
- Anaphase I: homologues separate; sister chromatids remain joined (reductional division).
- Telophase I: nuclei haploid; chromosomes still duplicated.
- Meiosis II: resembles mitosis; sister chromatids separate (equational division) → 4 unique haploid cells.
- Genetic variation sources
- Crossing over.
- Independent assortment (2ⁿ combinations; n = haploid number; humans: 2^{23} possibilities).
- Random fusion of gametes at fertilization.
- Errors
- Nondisjunction in Anaphase I or II → aneuploid gametes (e.g., trisomy 21); major cause of spontaneous abortion.
Comparative Highlights
- Mitosis vs Meiosis
- Synapsis/crossing over absent in mitosis.
- Mitosis produces 2 identical diploid cells; meiosis yields 4 non-identical haploid cells.
- Chromosome alignment: individual chromosomes (mitosis) vs homologous pairs (meiosis I).
Key Equations & Numbers
- Gibbs free energy: \Delta G = \Delta H - T\Delta S
- ATP hydrolysis: \text{ATP} \rightarrow \text{ADP} + P_i \; (\Delta G \approx -7.3 \text{ kcal·mol}^{-1})
- Cellular respiration yield (eukaryote):
- 6 CO2, 30\text{–}32\, \text{ATP}, 10\,\text{NADH}, 2\,\text{FADH}2 per glucose.
- Photosynthesis: 6 CO2 + 12H2O + \text{light} \rightarrow C6H{12}O6 + 6H2O + 6O_2.
Concept Integration & Real-World Relevance
- Phosphorylation cascades in signaling are mirrored in metabolic regulation (PFK, pyruvate dehydrogenase) and cell-cycle control (Cdk activity).
- Proton gradients drive ATP production in mitochondria and photosynthetic chloroplasts, illustrating chemiosmosis as a universal bioenergetic principle.
- Feedback mechanisms (allosteric inhibition, checkpoint arrest, p53-mediated apoptosis) underscore cellular economy and genomic integrity—disruption leads to pathologies such as cancer.